Transforming the organization delivery, and financing of the medical care systems in the Fox Valley to achieve lower costs, higher quality, and better outcomes.

Click here to view our proposed solution.



The opinions expressed in this blog are primarily those of Merton D. Finkler Ph.D., retired Distinguished Emeritus Professor of Economics at Lawrence University and William McLaughlin retired Founder President and CEO of Those opinions are based upon many years of education, scholarship, teaching and industry experience. Read their biographies at "Meet the Team" and make your own judgments about the veracity of their opinions.


Post Crescent Reporter Documents Problems with Oncology Services at ThedaCare

The Appleton Post Crescent has just published a story about problems experienced by oncology patients at ThedaCare following their absorption of Fox Valley Hematology and Oncology last summer. We encourage all of our subscribers to read the fine reporting by Maureen Wallenfang. Click here to read Maureen's story. It is reasonable to expect that any provider of service will, on occasion, fall short of customer expectations. In this case, however, we recognize one of the issues that Fox Valley Health Care forecast might be a result of the acquisition: significantly higher prices. One patient (who contacted us and we referred to Ms. Wallenfang) reported that his out-of-pocket cost for chemother


©2017-2020 by Fox Valley Health Care.